[PSP4-4] CD8 killer T cells and NK cells from iPSC for cancer immunotherapy
Abstract password authentication.
The password was sent to all registrants in email. You can also check it in abstracts and a live streamig site.
Presentation information
Presidential Special Program
[PSP4] Presidential Special Program④ CAR-T/TCR/NK and beyond：Breakthrough technologies for solid tumors
Sat. Jul 16, 2022 8:30 AM - 11:00 AM Room 1 (3F 302・303)
Chair persons :Hiroshi Shiku (Department of Personalized cancer Immunotherapy, Mie University Graduate School of Medicine ) , Yui Harada (Graduate School of Pharmaceutical Sciences, Kyushu University)